CDB15:0001481 TIMP3 — KDR

Experimentally validated in Human; Orthology-inferred in Mouse, Rat, Frog, Zebrafish, Chicken, Macaque, Pig, Dog, Cow, Chimp, Horse, Marmoset, Sheep

Title

Journal:; Year Published:

Abstract

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2.

Nature medicine, 2003; PubMed, Homo sapiens TIMP3 — Homo sapiens KDR
ABSTRACT: Tissue inhibitor of metalloproteinases-3 (TIMP3) is one of four members of a family of proteins that were originally classified according to their ability to inhibit matrix metalloproteinases (MMP). TIMP3, which encodes a potent angiogenesis inhibitor, is mutated in Sorsby fundus dystrophy, a macular degenerative disease with submacular choroidal neovascularization. In this study we demonstrate the ability of TIMP3 to inhibit vascular endothelial factor (VEGF)-mediated angiogenesis and identify the potential mechanism by which this occurs: TIMP3 blocks the binding of VEGF to VEGF receptor-2 and inhibits downstream signaling and angiogenesis. This property seems to be independent of its MMP-inhibitory activity, indicating a new function for this molecule.
Basic Information on TIMP3
Ligand Name: TIMP metallopeptidase inhibitor 3
Other Symbols: SFD
Ligand Location: secreted based on hpa, perplexity, uniprot
HGNC Gene Symbol Report: TIMP3
GeneCards: TIMP3
Interactions with other Receptors for TIMP3
Basic Information on KDR
Receptor Name: kinase insert domain receptor
Other Symbols: FLK1, VEGFR, VEGFR2, CD309
Receptor Location: cell membrane based on perplexity, uniprot
HGNC Gene Symbol Report: KDR
GeneCards: KDR
Interactions with other Ligands for KDR